# Perioperative Nitric Oxide Prevents Acute Kidney Injury in Acute Type A Aortic Dissection Patients

Study · id `cardio:ct-nct06622291` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06622291](<https://clinicaltrials.gov/study/NCT06622291>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06622291

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.

## Technical summary

Registry record NCT06622291. Randomized; double masking; primary purpose prevention. Start 2024-11-30 (actual); primary completion 2025-11-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 106 participants (enrolled count; ClinicalTrials.gov record NCT06622291, source copy `cardio:ctgov-nct06622291-2026-02-05`, retrieved 2026-11-18)
- Started: 2024-11-30 (actual) (ClinicalTrials.gov record NCT06622291, source copy `cardio:ctgov-nct06622291-2026-02-05`, retrieved 2026-11-18)
- Primary completion: 2025-11-01 (actual) (ClinicalTrials.gov record NCT06622291, source copy `cardio:ctgov-nct06622291-2026-02-05`, retrieved 2026-11-18)
- Completion: 2026-02-02 (actual) (ClinicalTrials.gov record NCT06622291, source copy `cardio:ctgov-nct06622291-2026-02-05`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT06622291, source copy `cardio:ctgov-nct06622291-2026-02-05`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06622291-2026-02-05`, retrieved 2026-11-18)

## The registry's words

- Brief title: Perioperative Nitric Oxide Prevents Acute Kidney Injury in Acute Type A Aortic Dissection Patients
- Condition: Acute Kidney Injury
- Condition: Nitrous Oxide
- Condition: Acute Type A Aortic Dissection
- Intervention (Drug): Nitric Oxide
- Intervention (Other): Placebo
- Lead sponsor: Beijing Anzhen Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic dissection (`cardio:aortic-dissection`)
- Registry lists this organization as the lead sponsor: Beijing Anzhen Hospital (`cardio:org-beijing-anzhen-hospital`)

## Provenance

Content hash: 6375786833f59aedadaac2857c667b9eeb23087d41adf36ba277d59b0c4dbe49
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
